Evidence supporting the use of: Vitamin E (beta-tocotrienol)
For the health condition: Radiation Sickness

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Beta-tocotrienol is one of the tocotrienol forms of vitamin E, which has been studied for its potential radioprotective effects. The rationale for its use in radiation sickness stems from its antioxidant properties and ability to modulate cellular mechanisms involved in oxidative stress and inflammation, which are key contributors to radiation-induced tissue damage. Several preclinical studies, primarily in animal models, have demonstrated that tocotrienols (including beta-tocotrienol) can reduce radiation-induced lethality and protect hematopoietic and gastrointestinal tissues. These effects are thought to be mediated by scavenging free radicals, enhancing DNA repair, and modulating cytokine expression.

However, most of the scientific evidence relates to the delta- and gamma-tocotrienol isoforms, which have shown more potent radioprotective effects in animal studies compared to alpha- or beta-tocotrienol. Human clinical data are scarce, and there are no widely accepted clinical guidelines endorsing the use of any tocotrienol form, including beta-tocotrienol, for the prevention or treatment of radiation sickness. The evidence is thus preliminary and largely preclinical, with further research needed to establish efficacy, optimal dosing, and safety in humans.

In summary, while there is scientific interest and some animal data supporting the use of beta-tocotrienol and related compounds for radiation protection, clinical validation is lacking, and its use is not standard in medical practice for radiation sickness.

More about Vitamin E (beta-tocotrienol)
More about Radiation Sickness

Products containing Vitamin E (beta-tocotrienol)

We currently have no products on Vitabase that contain this ingredient.